Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H31N3O5 |
Molecular Weight | 453.5307 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC1=C(OC[C@@H](O)CO)C(C)=CC(=C1)C2=NOC(=N2)C3=CC(OC)=NC(=C3)C4CCCC4
InChI
InChIKey=KJKKMMMRWISKRF-FQEVSTJZSA-N
InChI=1S/C25H31N3O5/c1-4-16-10-18(9-15(2)23(16)32-14-20(30)13-29)24-27-25(33-28-24)19-11-21(17-7-5-6-8-17)26-22(12-19)31-3/h9-12,17,20,29-30H,4-8,13-14H2,1-3H3/t20-/m0/s1
Cenerimod is an orally available sphingosine-1-phosphate receptor 1 (S1P1) modulator that is being developed by Idorsia Pharmaceuticals for the treatment of systemic lupus erythematosus. Sphingosine-1-phosphate (S1P), a lipid mediator, regulates lymphocyte migration between lymphoid tissue and blood. Cenerimod is a potent, selective, safe and orally administrable S1P1 receptor modulator, which reportedly reduced blood lymphocytes and attenuated murine experimental autoimmune encephalomyelitis (EAE) in a murine model. Cenerimod has potential as novel therapy with an improved safety profile for autoimmune diseases with a high unmet medical need.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/29211013
0.5, 1, 2 or 4 mg/day
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10183
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
300000010606
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
C169837
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
1262414-04-9
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
49871973
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
Y333RS1786
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
DB12705
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY | |||
|
EF-116
Created by
admin on Sat Dec 16 11:07:29 GMT 2023 , Edited by admin on Sat Dec 16 11:07:29 GMT 2023
|
PRIMARY |
ACTIVE MOIETY